Fortrea Holdings Inc.

NASDAQ:FTRE

Biotechnology

Healthcare
$20.50 -0.46%

-$0.07 today

Market cap
$1.94B
Beta
2.11
P/E (TTM)
-3.1
EPS (TTM)
-$4.90
52W Low $4.36High $18.67

Volume 1.59M

Average 1.31M

FTRE Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Fortrea Holdings Inc.NASDAQ: FTRE

Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026

Other non-cash items turns negative

Q2 FY2026 other non-cash items was -$12.8M, compared with $354.3M a year earlier. Trailing-twelve-month other non-cash items was -$5.1M. Over 3 fiscal years it compounded at +173.6% a year.

Context

  • Other non-cash items amounted to 31.7% of revenue in FY2025, up 29.9 pp from a year earlier.
  • Other non-cash items increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other non-cash items holds near -$12.8M or moves back toward the trailing-twelve-month quarterly average of -$1.28M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$12.8M+357.1% QoQ
Last fiscal yearDec 2025
$864.6M+1660.9% YoY
LTMJun 2026
-$5.1M-100.6% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-103.6%——
1 year+1660.9%——
3-year CAGR+173.6%——
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
864.6M USD
Year-over-year change
+1660.9%
4-year CAGR
+122.3%

Other Non-Cash Items vs competitors

How FTRE compares with its peers on the latest reported figures

  • FTRE's LTM Jun 2026 other non-cash items of $5.1M is the smallest of the 3 companies compared; the peer median is $25.61M.
  • Its year-over-year change of -100.6% is the lowest of 3, against a peer median of +134.4%.
  • Other non-cash items amounts to 0.2% of revenue for FTRE, versus a peer median of 3.7%.
FTRE Competitors Peer median
Other Non-Cash Items for FTRE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CERTCertara, Inc.LTM Mar 2026$27.41M +263.1%—6.5%
MEDPMedpace Holdings, Inc.LTM Sep 2026$23.82M +5.7%+11.7%0.8%
FTREFortrea Holdings Inc.LTM Jun 2026$5.1M -100.6%+173.6%0.2%
Peer median (excluding FTRE) $25.61M+134.4%+11.7%3.7%

Competitors are the stored peer set for FTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income98M186.2M(25.2M)(271.5M)(986.2M)
Depreciation & Amortization166.3M93.6M98M86.9M78M
Deferred Income Tax(30.2M)(16.5M)(41.6M)(24.6M)(32M)
Stock-Based Compensation27.5M25.4M42.7M58.4M74.4M
Change in Working Capital(127.2M)(248.2M)26.9M364.5M114.7M
Accounts Receivables(187.6M)(108.4M)(53.4M)309.9M70.9M
Inventory00000
Accounts Payables(6.2M)24.8M55.3M7.2M(109.9M)
Other Working Capital66.6M(164.6M)25M47.4M153.7M
Other Non-Cash Items35.4M42.2M67.6M49.1M864.6M
Operating Cash Flow169.8M82.7M168.4M262.8M113.5M
Capital Expenditures(26.5M)(54.4M)(40.3M)(25.5M)(25.2M)
Acquisitions (Net)000276.6M0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities300K400K8.5M500K39.6M
Investing Cash Flow(26.2M)(54M)(31.8M)251.6M14.4M
Debt Repayment001.62B(482.7M)(76.3M)
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(128.5M)(6.3M)(1.76B)(15.1M)0
Financing Cash Flow(128.5M)(6.3M)(140.8M)(497.8M)(76.3M)
Effect of Forex Changes(800K)(6.6M)2.4M(6.7M)4.5M
Net Change in Cash14.3M15.8M(1.8M)9.9M56.1M
Free Cash Flow143.3M28.3M128.1M237.3M88.3M

Fortrea Holdings Inc.

NASDAQ:FTRE

Intrinsic Alpha fair value

Locked

Current Price

$20.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.